Zadnji put ažurirano :
29/10/2024
lijek protiv karcinoma   Pentostatin  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Nipent Francuska, Grčka, Irska, Italija, Nizozemska, Njemačka, novi Zeland, Portugal, S A D, Slovenija, Španjolska, Velika Britanija
Bibliografija   injekcija   Bibliografija : Pentostatin  
Vrsta Publikacija
154 Časopis Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ.
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Pharm Res 1990 ; 7: 452-460.
169 Časopis Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
248 Časopis Trissel LA, Martinez JF.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Am J Hosp Pharm 1993 ; 50: 300-304.
334 Časopis Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335 Časopis Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
492 Časopis Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.

  Mentions Légales